Alzamend Neuro Inc (ALZN) vs Scienture Holdings, Inc. (SCNX)
A side-by-side comparison of Alzamend Neuro Inc and Scienture Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALZN
Alzamend Neuro Inc
$1.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SCNX
Scienture Holdings, Inc.
$3.76HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALZN vs SCNX
growth of $100 · dividends reinvested · last 2yALZN -94.5% (-76.6%/yr)SCNX -98.0% (-85.9%/yr)ALZN compounded faster over this window
ALZN SCNX
ALZN vs SCNX: by the numbers
- •SCNX is the larger company ($6M vs $5M market cap).
- •Both run net losses; ALZN's is the smaller (0.00% vs -4620.92% net margin).
Metrics side by side
Valuation
| Metric | ALZN | SCNX |
|---|---|---|
| P/S ratio | N/A | 7.44 |
| P/B ratio | 0.90 | 0.10 |
Profitability
| Metric | ALZN | SCNX |
|---|---|---|
| Gross margin | 0.00% | 76.80% |
| Operating margin | 0.00% | -3763.78% |
| Net margin | 0.00% | -4620.92% |
| ROE | -156.77% | -59.21% |
| ROIC | -156.69% | -15.99% |
Growth (annualized)
| Metric | ALZN | SCNX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -42.69% |
| Total return CAGR (5Y) | -79.14% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.